发明名称 ALZHEIMER'S DISEASE DIAGNOSTIC DRUG
摘要 PROBLEM TO BE SOLVED: To simply perform mass treatment with high reliability by using L-glutamic acidα-p-nitroanilide (Glu-pNA) as an effect component. SOLUTION: A blood plasma specimen and a physiological saline soln. are distributed to an Eppendorf tube. Before the start of reaction, a reaction buffer soln. is added to a substrate of L-glutamic acidα-p-nitroanilide to prepare a reaction soln. which is, in turn, added to the Eppendorf tube to perform incubation. After a definite time, acetic acid with a predetermined concn. is added to stop reaction. The absorbancy of a blank and the absorbancy originating from the specimen are substracted to calculate a substantial absorbancy change by enzymatic reaction. By this constitution, only in a case using Glu-pNA as a substrate, the lowering of the activity of aminopeptitase (GAP) in blood of an Alzhemer's disease patient is obtained.
申请公布号 JPH09196912(A) 申请公布日期 1997.07.31
申请号 JP19960008620 申请日期 1996.01.22
申请人 TOKYO MET GOV RINSHIYOU IGAKU SOGO KENKYUSHO;CHUGAI PHARMACEUT CO LTD 发明人 NISHIMICHI TAKAOMI;OTSUKA MITSUO;KUDA TAKASHI
分类号 G01N33/48;(IPC1-7):G01N33/48 主分类号 G01N33/48
代理机构 代理人
主权项
地址